SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (1917)4/16/1999 12:23:00 PM
From: Mama Bear  Respond to of 2135
 
Peter, what you quote from the press release does not even come close to calling ENMD a scam or crooked, or saying that bankruptcy is imminent.

I'm sorry that you have a problem with opposing points of view.

Barb



To: Biomaven who wrote (1917)6/8/1999 9:20:00 AM
From: LLCF  Read Replies (1) | Respond to of 2135
 
Peter... in your opinion is endostatin any better than some of the other "anti-angiogenesis" drugs currently more advanced in trials [SUGN]???? What is your ETM [estimated time to market] for endostatin? Does ENMD have other cancer products expected to come out soon? Overall opinion on ENMD?

Thanks in advance.

DAK